A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI

BACKGROUND: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival. Several outcome studies support this view particularly if the patient is to be started on clopidogrel due to the prevalence of clopidogrel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian Heart J
Autors principals: Rath, P.C., Chidambaram, Sundar, Rath, Pallavi, Dikshit, Byomakesh, Naik, Sudhir, Sahoo, Prashant K., Das, Brajraj, Mahalingam, Mohanshankar, Khandrika, Lakshmipathi, Jain, Jugnu
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475902/
https://ncbi.nlm.nih.gov/pubmed/26071289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.03.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars